… Moreover, there are some practical obstacles to the implementation of 68 Ga-DOTA-peptide
PET that may differ from country to country. Examples are lack of 68 Ge/ 68 …

… the results of somatostatin receptor (SSTR) PET/CT imaging using 68 Ga-DOTA-conjugated
peptides, as well as 18 F-DOPA imaging for various neuroendocrine neoplasms. …

… evaluate the impact of 68 Ga-labelled DOTA 0 -lanreotide ( 68 Ga-DOTA-LAN) on … somatostatin
receptor (SSTR) scintigraphy or 68 Ga-labelled DOTA 0 ,Tyr 3 -octreotide ( 68 Ga-DOTA-…

… Somatostatin receptor imaging has previously been … , while [ 68 Ga]Ga-labelled compounds
and PET/CT imaging has … ([ 18 F]FDG) PET/CT has emerged as an important tool to define …

… of DOTA by the NODAGA chelator was able to substantially increase the binding affinity of
the Ga(III)-NODAGA analogs, compared with the Ga(III)-DOTA … PET of somatostatin receptor–…

… to describe the value of 68 Ga-DOTA-TOC PET for assessing radionuclide therapy in patients
with SSTR-positive tumors. In our setting, 68 Ga-DOTA-TOC PET was used not only as a …

… Somatostatin receptor PET with 68 Ga-DOTA-TOC is superior for the detection of NET
compared with SPECT and diagnostic CT in various clinical situations (initial diagnosis, staging, …

… -DOTA-SSTRTs PET/CT is used as a baseline procedure before starting target treatment
with somatostatin … metastases is another common indication of 68Ga-DOTA-SSTRTs PET/CT. …

… groups to study [ 68 Ga-DOTA]-TOC in patients with somatostatin receptor-positive tumours
[… DOTA-TOC by virtue of an improved somatostatin receptor subtype profile [33, 34]. In PET …

… We conclude that 66 Ga labeled DOTATOC can be used for PET diagnosis and quantitative
… investigated somatostatin receptor targeting characteristics of 66 Ga-DOTATOC in an animal …